Danish Originals S2 E3: Mads Refslund

In this episode of the art and business podcast Danish Originals, Michelin-starred chef Mads Refslund, co-founder of Noma, talks about rethinking front and back of house service, growing up in New York, and his earliest memories of food and flavour.

From his new restaurant Ilis in Greenpoint, Brooklyn in New York City, Michelin-starred Danish chef Mads Refslund talks about the central role of the root cellar, and rethinking the front of house and back of house model so that chefs are also the ones talking with diners about the food.

Mads, a co-founder of Copenhagen’s world renowned Noma, additionally shares memories about his start in New York and the influence of his parents and his grandparents in paving his path with food.

Mads selects and discusses a work by Poul Anker Bech from the SMK collection.

Listen to Danish Originals on Spotify.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.